Speaker Details

Ruth Ann Vleugels, MD, MBA, MPH, FAAD

Ruth Ann Vleugels, MD, MBA, MPH, FAAD

Mass General Brigham

BIOGRAPHY

Ruth Ann Vleugels, MD, MPH, MBA is Professor of Dermatology at Harvard Medical School and the Heidi and Scott C. Schuster Distinguished Chair in Dermatology and Senior Medical Director at Mass General Brigham. She serves as the Director of the Autoimmune Skin Disease Program, Connective Tissue Disease Clinics, and Atopic Dermatitis Program at Brigham and Women’s Hospital and Co-Director of the Rheumatology-Dermatology Program at Boston Children’s Hospital. Dr. Vleugels developed and serves as the Program Director of the Brigham and Women's Hospital Dermatology-Rheumatology Fellowship, which is the only formal training opportunity of its kind nationwide. She is Past President of the New England Dermatologic Society and Rheumatologic Dermatology Society. She was elected to the Board of Directors of the American Academy of Dermatology to help lead the world’s largest dermatologic society, which represents more than 20,000 physicians. An international expert in autoimmune connective tissue diseases, Dr. Vleugels’ clinical research focuses on rare autoimmune skin diseases and emerging medical therapies.

SESSIONS

S025 JAK Inhibitors: A New Frontier in Dermatology
Mar 28, 2026 9:00 AM - 12:00 PM Bluebird 1A
S034 Late-Breaking Research: Session 2
Mar 28, 2026 1:00 PM - 4:00 PM Bellco Theatre
S048 What’s Hot in Autoimmune Connective Tissue Disease
Mar 29, 2026 1:00 PM - 4:00 PM Bluebird 1C

DISCLOSURES

AbbVie – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Astra Zeneca – Consultant (1099 relationship)(Honoraria); BMS – Consultant (1099 relationship)(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Priovant Therapeutics – Consultant (1099 relationship)(Honoraria);